EVOKE PHARMA, INC. Deferred Tax Liabilities, Gross
EVOKE PHARMA, INC. had Deferred Tax Liabilities, Gross of $36.00 thousand as of 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2025-03-13
- 2024-12-31: Deferred Tax Liabilities, Gross $36.00K.
- 2022-12-31: Deferred Tax Liabilities, Gross $29.00K.
- 2021-12-31: Deferred Tax Liabilities, Gross $3.00K.
- 2020-12-31: Deferred Tax Liabilities, Gross $59.00K.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2024-12-31 | $36.00K 10-K · filed 2025-03-13 |
| 2022-12-31 | $29.00K 10-K/A · filed 2024-05-14 |
| 2021-12-31 | $3.00K 10-K · filed 2023-03-21 |
| 2020-12-31 | $59.00K 10-K · filed 2022-03-08 |
| 2019-12-31 | $39.00K 10-K · filed 2021-03-11 |